Spot Trading’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.44M Sell
44,200
-58,200
-57% -$4.83M 0.06% 441
2017
Q2
$9.09M Buy
102,400
+61,800
+152% +$5.21M 0.18% 95
2017
Q1
$3.27M Buy
40,600
+36,900
+997% +$2.88M 0.11% 178
2016
Q4
$264K Buy
3,700
+2,000
+118% +$157K 0.01% 1775
2016
Q3
$147K Sell
1,700
-104,800
-98% -$9.13M ﹤0.01% 2262
2016
Q2
$9.24M Sell
106,500
-19,900
-16% -$1.61M 0.16% 120
2016
Q1
$9.48M Buy
126,400
+7,400
+6% +$557K 0.17% 133
2015
Q4
$9.15M Sell
119,000
-267,700
-69% -$20.2M 0.1% 263
2015
Q3
$25.9M Buy
386,700
+276,100
+250% +$20.3M 0.25% 54
2015
Q2
$8.2M Buy
110,600
+24,600
+29% +$1.88M 0.08% 335
2015
Q1
$6.71M Buy
86,000
+33,600
+64% +$2.55M 0.07% 400
2014
Q4
$3.78M Sell
52,400
-11,500
-18% -$799K 0.02% 976
2014
Q3
$3.96M Buy
63,900
+37,600
+143% +$2.39M 0.02% 1094
2014
Q2
$1.68M Sell
26,300
-86,000
-77% -$5.22M 0.01% 1767
2014
Q1
$6.91M Buy
112,300
+78,300
+230% +$4.56M 0.04% 652
2013
Q4
$1.95M Sell
34,000
-20,500
-38% -$1.16M 0.01% 1517
2013
Q3
$2.9M Sell
54,500
-15,800
-22% -$850K 0.02% 1105
2013
Q2
$3.62M Buy
+70,300
New +$3.48M 0.02% 929

Other funds holding MDT

Spot Trading's MDT Position: Q3 2017 in Review

Spot Trading increased its Medtronic (MDT) stake by 209% in Q3 2017, buying an estimated $4.6M and bringing the position to 81,966 shares worth $6.37M. The position accounts for 0.11% of the portfolio, ranked #201.

Spot Trading first reported a position in MDT in Q2 2013 and has held it in 14 quarters since. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Spot Trading held 81,966 shares of Medtronic worth $6.37M as of Q3 2017.
  • Spot Trading bought 55,446 Medtronic shares in Q3 2017, an estimated $4.6M.
  • Medtronic made up 0.11% of Spot Trading's portfolio in Q3 2017, its #201 holding.
  • Spot Trading first reported a position in Medtronic in Q2 2013 and has held it in 14 quarters since.
  • 1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.